Hydroxyprogesterone Caproate
- Product NDC
- 0517-1767
- 11-digit product format
- 005171767
- Labeler code
- 0517
- Product ID
- 0517-1767_4207c2b1-a227-4a27-9768-557a02ec4791
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydroxyprogesterone Caproate
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Labeler
- American Regent, Inc.
- Application
- ANDA210723
- Marketing category
- ANDA
- Marketing start
- 2018-06-28
- Marketing end
- 0000-00-00
- Substance
- HYDROXYPROGESTERONE CAPROATE
- Active strength
- 250 mg/mL
- Pharmacologic classes
- Progesterone Congeners [CS],Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 0517-1767 | | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 0517-1767 | 0517-1767-01 | D | Discontinued by firm | | 2026-07-31 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0517-1767-01 | 00517176701 | 1 VIAL in 1 BOX (0517-1767-01) > 1 mL in 1 VIAL | 1 vial | 2018-06-28 | 0000-00-00 | No | No | Current |